Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved Localization of Insulinomas Using 68Ga-NODAGA-Exendin-4 PET/CT.
Boss M, Eriksson O, Mikkola K, Eek A, Brom M, Buitinga M, Brouwers AH, Velikyan I, Waser B, Kauhanen S, Solin O, Marciniak C, Eriksson B, Reubi JC, Aveline C, Wild D, Pattou F, Talbot JN, Hofland J, Sundin A, Nuutila P, Hermans J, Gotthardt M. Boss M, et al. Among authors: brouwers ah. J Nucl Med. 2024 Dec 3;65(12):1959-1964. doi: 10.2967/jnumed.124.268158. J Nucl Med. 2024. PMID: 39419553 Free PMC article.
124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET).
Kist JW, de Keizer B, van der Vlies M, Brouwers AH, Huysmans DA, van der Zant FM, Hermsen R, Stokkel MP, Hoekstra OS, Vogel WV; THYROPET Study Group; other members of the THYROPET Study group are John M.H. de Klerk. Kist JW, et al. Among authors: brouwers ah. J Nucl Med. 2016 May;57(5):701-7. doi: 10.2967/jnumed.115.168138. Epub 2015 Nov 25. J Nucl Med. 2016. PMID: 26609180 Free article. Clinical Trial.
89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer.
Verhoeff SR, van de Donk PP, Aarntzen EHJG, Oosting SF, Brouwers AH, Miedema IHC, Voortman J, Menke-van der Houven van Oordt WC, Boellaard R, Vriens D, Slingerland M, Hermsen R, Grunsven IVE, Heskamp S, van Herpen CML. Verhoeff SR, et al. Among authors: brouwers ah. J Nucl Med. 2022 Oct;63(10):1523-1530. doi: 10.2967/jnumed.121.263470. Epub 2022 May 5. J Nucl Med. 2022. PMID: 35512998 Free PMC article.
89Zr-bevacizumab PET imaging in primary breast cancer.
Gaykema SB, Brouwers AH, Lub-de Hooge MN, Pleijhuis RG, Timmer-Bosscha H, Pot L, van Dam GM, van der Meulen SB, de Jong JR, Bart J, de Vries J, Jansen L, de Vries EG, Schröder CP. Gaykema SB, et al. Among authors: brouwers ah. J Nucl Med. 2013 Jul;54(7):1014-8. doi: 10.2967/jnumed.112.117218. Epub 2013 May 7. J Nucl Med. 2013. PMID: 23651946 Free article. Clinical Trial.
Ultrashort Oncologic Whole-Body [18F]FDG Patlak Imaging Using LAFOV PET.
van Sluis J, van Snick JH, Glaudemans AWJM, Slart RHJA, Noordzij W, Brouwers AH, Dierckx RAJO, Lammertsma AA, Tsoumpas C, Boellaard R. van Sluis J, et al. Among authors: brouwers ah. J Nucl Med. 2024 Oct 1;65(10):1652-1657. doi: 10.2967/jnumed.124.267784. J Nucl Med. 2024. PMID: 39353647
Assessment of Bone Lesions with 18F-FDG PET Compared with 99mTc Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
van Es SC, Velleman T, Elias SG, Bensch F, Brouwers AH, Glaudemans AWJM, Kwee TC, Iersel MW, Maduro JH, Oosting SF, de Vries EGE, Schröder CP. van Es SC, et al. Among authors: brouwers ah. J Nucl Med. 2021 Feb;62(2):177-183. doi: 10.2967/jnumed.120.244640. Epub 2020 Aug 17. J Nucl Med. 2021. PMID: 32817140 Free article.
169 results